跳至主要内容
临床试验/JPRN-UMIN000041822
JPRN-UMIN000041822已完成未知

Prospective study analyzed the association between efficacy and adverse events by Atezolizumab immunotherapy and diversity or species of fecal microbiota in advanced /reccurent non-small cell lung cancer patients - Prospective study analyzed the association between efficacy and adverse events by Atezolizumab immunotherapy and diversity or species of fecal microbiota in advanced /reccurent non-small cell lung cancer patients

ational Hospital Organization Kyushu Medical Center, Clinical Research Institute0 个研究点目标入组 60 人开始时间: 2020年10月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
60